Literature DB >> 16585574

IFN-gamma enhances production of nitric oxide from macrophages via a mechanism that depends on nucleotide oligomerization domain-2.

Sabine Tötemeyer1, Mark Sheppard, Adrian Lloyd, David Roper, Christopher Dowson, David Underhill, Peter Murray, Duncan Maskell, Clare Bryant.   

Abstract

Pattern recognition receptors are central to the responsiveness of various eukaryotic cell types when they encounter pathogen-associated molecular patterns. IFN-gamma is a cytokine that is elevated in humans and other animals with bacterial infection and enhances the LPS-induced production of antibacterial mediators by macrophages. Mice lacking the pattern recognition receptor, TLR4, respond very poorly to stimulation by LPS, but administration of IFN-gamma has been described as restoring apparent sensitivity to this stimulatory ligand. In this study, we show that IFN-gamma primes murine macrophages stimulated by crude LPS preparations to produce the antibacterial mediator NO, a proportion of which is independent of TLRs 2 and 4. This response is lost in tlr4-/- IFN-gamma-primed murine macrophages when the LPS preparation is highly purified. NO is also induced if chemically synthesized muramyl dipeptide, an intermediate in the biosynthesis of peptidoglycan, is used to stimulate macrophages primed with IFN-gamma. This is absolutely dependent on the presence of a functional nucleotide oligomerization domain-2 (NOD-2) protein. IFN-gamma increases NOD-2 expression and dissociates this protein from the actin cytoskeleton within the cell. IFN-gamma priming of macrophages therefore reveals a key proinflammatory role for NOD-2. This study also shows that the effect of IFN-gamma in restoring inflammatory responses to gram-negative bacteria or bacterial products in mice with defective TLR4 signaling is likely to be due to a response to peptidoglycan, not LPS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16585574     DOI: 10.4049/jimmunol.176.8.4804

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

Review 1.  Digesting the genetics of inflammatory bowel disease: insights from studies of autophagy risk genes.

Authors:  Amrita Kabi; Kourtney P Nickerson; Craig R Homer; Christine McDonald
Journal:  Inflamm Bowel Dis       Date:  2011-09-20       Impact factor: 5.325

2.  A novel pathway for inducible nitric-oxide synthase activation through inflammasomes.

Authors:  Carina L Buzzo; Julia C Campopiano; Liliana M Massis; Silvia L Lage; Alexandra A Cassado; Rafael Leme-Souza; Larissa D Cunha; Momtchilo Russo; Dario S Zamboni; Gustavo P Amarante-Mendes; Karina R Bortoluci
Journal:  J Biol Chem       Date:  2010-08-11       Impact factor: 5.157

3.  Intracellular pathogen sensor NOD2 programs macrophages to trigger Notch1 activation.

Authors:  Kushagra Bansal; Kithiganahalli N Balaji
Journal:  J Biol Chem       Date:  2010-12-14       Impact factor: 5.157

Review 4.  The Nodosome: Nod1 and Nod2 control bacterial infections and inflammation.

Authors:  Ivan Tattoli; Leonardo H Travassos; Leticia A Carneiro; Joao G Magalhaes; Stephen E Girardin
Journal:  Semin Immunopathol       Date:  2007-08-10       Impact factor: 9.623

5.  The TLR2-MyD88-NOD2-RIPK2 signalling axis regulates a balanced pro-inflammatory and IL-10-mediated anti-inflammatory cytokine response to Gram-positive cell walls.

Authors:  Lilian O Moreira; Karim C El Kasmi; Amber M Smith; David Finkelstein; Sophie Fillon; Yun-Gi Kim; Gabriel Núñez; Elaine Tuomanen; Peter J Murray
Journal:  Cell Microbiol       Date:  2008-06-28       Impact factor: 3.715

6.  Activation of mitogen-activated protein kinases by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) plays an important role in macrophage stimulation.

Authors:  Jing Sun; Liang-Chuan S Wang; Zvi G Fridlender; Veena Kapoor; Guanjun Cheng; Lai-Ming Ching; Steven M Albelda
Journal:  Biochem Pharmacol       Date:  2011-07-26       Impact factor: 5.858

7.  Activation of the Intracellular Pattern Recognition Receptor NOD2 Promotes Acute Myeloid Leukemia (AML) Cell Apoptosis and Provides a Survival Advantage in an Animal Model of AML.

Authors:  Nathaniel J Buteyn; Ramasamy Santhanam; Giovanna Merchand-Reyes; Rakesh A Murugesan; Gino M Dettorre; John C Byrd; Anasuya Sarkar; Sumithira Vasu; Bethany L Mundy-Bosse; Jonathan P Butchar; Susheela Tridandapani
Journal:  J Immunol       Date:  2020-02-24       Impact factor: 5.422

8.  Effective, broad spectrum control of virulent bacterial infections using cationic DNA liposome complexes combined with bacterial antigens.

Authors:  Robin Ireland; Norma Olivares-Zavaleta; Jonathan M Warawa; Frank C Gherardini; Clayton Jarrett; B Joseph Hinnebusch; John T Belisle; Jeffery Fairman; Catharine M Bosio
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

9.  Toll-like receptor 4 signalling through MyD88 is essential to control Salmonella enterica serovar typhimurium infection, but not for the initiation of bacterial clearance.

Authors:  Suzanne Talbot; Sabine Tötemeyer; Masahiro Yamamoto; Shizuo Akira; Katherine Hughes; David Gray; Tom Barr; Pietro Mastroeni; Duncan J Maskell; Clare E Bryant
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

10.  The NOD/RIP2 pathway is essential for host defenses against Chlamydophila pneumoniae lung infection.

Authors:  Kenichi Shimada; Shuang Chen; Paul W Dempsey; Rosalinda Sorrentino; Randa Alsabeh; Anatoly V Slepenkin; Ellena Peterson; Terence M Doherty; David Underhill; Timothy R Crother; Moshe Arditi
Journal:  PLoS Pathog       Date:  2009-04-10       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.